
1. Technology overview
Sentante, operated by UAB Inovatyvi Medicina (Vytauto pr. 23, Kaunas, Lithuania), develops robotic systems for endovascular interventions. The company states it was founded in 2017 and its work is co-financed under EU projects for a neurovascular robotic system and a digital inflator.
The platform is a haptic, device-agnostic robot for catheter and guidewire procedures, with a bedside unit in the operating room and a control suite. It senses force and torque at the catheter drive, uses a 1:1 motion-mimicking interface so interventionalists can operate without retraining, and records force, kinematics and time-aligned fluoroscopy for each procedure. The CE mark was announced in May 2026.
2. Highlighted features & specifications
- Haptic control: force and torque sensing at the catheter drive.
- Motion mimicking: 1:1 interface that follows the operator's hand movements.
- Device agnostic: works with standard catheters and guidewires.
- Data capture: records force, kinematics and time-aligned fluoroscopy.
- Edge compute: NVIDIA Jetson AGX integrated in the latest robot.
- Applications: peripheral arterial intervention, embolisation and interventional oncology.
3. Potential application
Large Vietnamese hospitals with cath labs can evaluate the platform for peripheral arterial intervention and embolisation. Interventional oncology units can use it for embolisation procedures. Training centers can use recorded force data for operator skill assessment.
4. Benefits
Gives force-aware, consistent catheter handling in endovascular procedures. Lets existing interventionalists operate without retraining through a 1:1 motion-mimicking interface. Works with standard catheter and guidewire portfolios and fits existing cath-lab infrastructure. Records procedure data intended to support future AI capabilities.
5. Market trends & opportunities
Endovascular robotics is moving toward remote and data-driven procedures that reduce operator radiation exposure and extend specialist access. Vietnamese and Southeast Asian hospitals with limited interventional specialists outside major cities are a potential audience for teleoperated platforms over time.
6. Other information
Legal entity UAB Inovatyvi Medicina, Kaunas. CE mark May 2026; FDA Breakthrough Device Designation for the remote stroke programme in September 2025. Two EU-co-financed projects listed (about EUR 2.0M and EUR 0.87M EU funding). NVIDIA Inception member. Discovered via EIC-related lists; the site does not mention EIC Accelerator.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































